Regulatory affairs & submissions · Pharma & nutraceutical manufacturing
Keep every product registered and on file.
A drug-listing renewal slips its FDA window and a structure/function claim ships without the 30-day notice. Each gap pulls a product off the shelf.
The reality
Registration runs on fixed FDA windows.
Drug products carry establishment registration and drug listing in SPL format through eDRLS, with annual registration renewal between October 1 and December 31 and listing updates each June and December. Dietary supplements sit under a different regime — food facility registration, 21 CFR 111 cGMP, and a structure/function claim notification due within 30 days of first marketing. Tracked in a spreadsheet, the deadline that slips is the one that pulls a product off the shelf.
The operator holds both calendars, maps each product to the right obligation, assembles the SPL listing or claim notification with the label and supporting documents, drafts responses to FDA correspondence, and submits through the FDA gateway before the window closes.
How the operator runs regulatory affairs & submissions
Reg calendar · Q4
tracking- Annual registration renewed (Oct–Dec)
- June drug listing update filed
- Structure/function notice due in 30 days
01Track the obligations
Holds the registration calendar — drug listing windows, supplement claim notices, and open FDA correspondence with deadlines.
Filing SUB-1142 · S/F notification
preparing- Claim text and DSHEA disclaimer attached
- Formulation and label included
- Substantiation on file confirmed
02Prepare the package
Assembles the filing — current label, formulation, and supporting docs — checked against the right rule for the product type.
Filing SUB-1142 · status
submitted- Filed before the 30-day deadline
- FDA acknowledgement received
- Tracking to final disposition
03Submit & confirm
Files through the FDA gateway, logs the receipt, and tracks the submission to acknowledgement.
The outcome
40% of regulatory admin off the team
Keep products registered and submissions current.
- No deadline slips because every registration window and notice date is tracked and surfaced early
- Each product mapped to the right regime — drug listing in SPL for drugs, DSHEA claim notification and 21 CFR 111 for supplements
- FDA correspondence answered inside the response window
Common questions
Regulatory affairs & submissions
- What does the Regulatory affairs & submissions operator do?
- The operator holds both calendars, maps each product to the right obligation, assembles the SPL listing or claim notification with the label and supporting documents, drafts responses to FDA correspondence, and submits through the FDA gateway before the window closes.
- What impact does the Regulatory affairs & submissions operator have?
- 40% of regulatory admin off the team. Keep products registered and submissions current.
- How does the Regulatory affairs & submissions operator work?
- Holds the registration calendar — drug listing windows, supplement claim notices, and open FDA correspondence with deadlines. Assembles the filing — current label, formulation, and supporting docs — checked against the right rule for the product type. Files through the FDA gateway, logs the receipt, and tracks the submission to acknowledgement.
More operators in Pharma & nutraceutical manufacturing
See the full catalogue →



